Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Proposal to Detect Dark Matter using Axionic Topological Antiferromagnets.

Marsh DJE, Fong KC, Lentz EW, Šmejkal L, Ali MN.

Phys Rev Lett. 2019 Sep 20;123(12):121601. doi: 10.1103/PhysRevLett.123.121601.

PMID:
31633991
2.

Toward Systems Pathology for PTEN Diagnostics.

Haddadi N, Travis G, Nassif NT, Simpson AM, Marsh DJ.

Cold Spring Harb Perspect Med. 2019 Oct 15. pii: a037127. doi: 10.1101/cshperspect.a037127. [Epub ahead of print]

PMID:
31615872
3.

Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum.

Haas DM, Parker CB, Marsh DJ, Grobman WA, Ehrenthal DB, Greenland P, Bairey Merz CN, Pemberton VL, Silver RM, Barnes S, McNeil RB, Cleary K, Reddy UM, Chung JH, Parry S, Theilen LH, Blumenthal EA, Levine LD, Mercer BM, Simhan H, Polito L, Wapner RJ, Catov J, Chen I, Saade GR; NHLBI nuMoM2b Heart Health Study.

J Am Heart Assoc. 2019 Oct;8(19):e013092. doi: 10.1161/JAHA.119.013092. Epub 2019 Sep 30.

4.

Strong Constraints on Fuzzy Dark Matter from Ultrafaint Dwarf Galaxy Eridanus II.

Marsh DJE, Niemeyer JC.

Phys Rev Lett. 2019 Aug 2;123(5):051103. doi: 10.1103/PhysRevLett.123.051103.

PMID:
31491323
5.

Is an Energy Surplus Required to Maximize Skeletal Muscle Hypertrophy Associated With Resistance Training.

Slater GJ, Dieter BP, Marsh DJ, Helms ER, Shaw G, Iraki J.

Front Nutr. 2019 Aug 20;6:131. doi: 10.3389/fnut.2019.00131. eCollection 2019. Review.

6.

Differences in visceral adipose tissue and biochemical cardiometabolic risk markers in elite rugby union athletes of Caucasian and Polynesian descent.

Zemski AJ, Keating SE, Broad EM, Marsh DJ, Hind K, Walters KJ, Slater GJ.

Eur J Sport Sci. 2019 Sep 19:1-12. doi: 10.1080/17461391.2019.1656291. [Epub ahead of print]

PMID:
31409209
7.

Phase-Specific Changes in Rate of Force Development and Muscle Morphology Throughout a Block Periodized Training Cycle in Weightlifters.

Suarez DG, Mizuguchi S, Hornsby WG, Cunanan AJ, Marsh DJ, Stone MH.

Sports (Basel). 2019 May 28;7(6). pii: E129. doi: 10.3390/sports7060129.

8.

The nephron-arterial network and its interactions.

Marsh DJ, Postnov DD, Sosnovtseva OV, Holstein-Rathlou NH.

Am J Physiol Renal Physiol. 2019 May 1;316(5):F769-F784. doi: 10.1152/ajprenal.00484.2018. Epub 2019 Feb 13.

PMID:
30759020
9.

Writing Histone Monoubiquitination in Human Malignancy-The Role of RING Finger E3 Ubiquitin Ligases.

Marsh DJ, Dickson KA.

Genes (Basel). 2019 Jan 18;10(1). pii: E67. doi: 10.3390/genes10010067. Review.

10.

Same-Day Vs Consecutive-Day Precision Error of Dual-Energy X-Ray Absorptiometry for Interpreting Body Composition Change in Resistance-Trained Athletes.

Zemski AJ, Hind K, Keating SE, Broad EM, Marsh DJ, Slater GJ.

J Clin Densitom. 2019 Jan - Mar;22(1):104-114. doi: 10.1016/j.jocd.2018.10.005. Epub 2018 Oct 29.

PMID:
30454952
11.

Preseason Body Composition Adaptations in Elite White and Polynesian Rugby Union Athletes.

Zemski AJ, Keating SE, Broad EM, Marsh DJ, Hind K, Slater GJ.

Int J Sport Nutr Exerc Metab. 2018 Oct 4:1-9. doi: 10.1123/ijsnem.2018-0059. [Epub ahead of print]

PMID:
29757054
12.

Prescription and Other Medication Use in Pregnancy.

Haas DM, Marsh DJ, Dang DT, Parker CB, Wing DA, Simhan HN, Grobman WA, Mercer BM, Silver RM, Hoffman MK, Parry S, Iams JD, Caritis SN, Wapner RJ, Esplin MS, Elovitz MA, Peaceman AM, Chung J, Saade GR, Reddy UM.

Obstet Gynecol. 2018 May;131(5):789-798. doi: 10.1097/AOG.0000000000002579.

13.

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features.

Gill AJ, Lim G, Cheung VKY, Andrici J, Perry-Keene JL, Paik J, Sioson L, Clarkson A, Sheen A, Luxford C, Elston MS, Meyer-Rochow GY, Nano MT, Kruijff S, Engelsman AF, Sywak M, Sidhu SB, Delbridge LW, Robinson BG, Marsh DJ, Toon CW, Chou A, Clifton-Bligh RJ.

Am J Surg Pathol. 2019 Jan;43(1):35-46. doi: 10.1097/PAS.0000000000001017.

14.

Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer.

Shah JS, Gard GB, Yang J, Maidens J, Valmadre S, Soon PS, Marsh DJ.

Gynecol Oncol. 2018 Jan;148(1):181-188. doi: 10.1016/j.ygyno.2017.11.005. Epub 2017 Nov 10.

PMID:
29132874
15.

Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency.

Cole AJ, Zhu Y, Dwight T, Yu B, Dickson KA, Gard GB, Maidens J, Valmadre S, Gill AJ, Clifton-Bligh R, Marsh DJ.

Sci Data. 2017 Sep 5;4:170120. doi: 10.1038/sdata.2017.120.

16.

Searching for the QCD Axion with Gravitational Microlensing.

Fairbairn M, Marsh DJE, Quevillon J.

Phys Rev Lett. 2017 Jul 14;119(2):021101. doi: 10.1103/PhysRevLett.119.021101. Epub 2017 Jul 11.

PMID:
28753376
17.

Architecture of the rat nephron-arterial network: analysis with micro-computed tomography.

Marsh DJ, Postnov DD, Rowland DJ, Wexler AS, Sosnovtseva OV, Holstein-Rathlou NH.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F351-F360. doi: 10.1152/ajprenal.00092.2017. Epub 2017 Apr 19.

18.

Lessons learnt from outstanding mid-career women in endocrine cancer research.

Marsh DJ, Eng C.

Endocr Relat Cancer. 2016 Nov;23(11):E5-E7. No abstract available.

PMID:
27935806
19.

The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer.

Dickson KA, Cole AJ, Gill AJ, Clarkson A, Gard GB, Chou A, Kennedy CJ, Henderson BR; Australian Ovarian Cancer Study (AOCS), Fereday S, Traficante N, Alsop K, Bowtell DD, deFazio A, Clifton-Bligh R, Marsh DJ.

Hum Mol Genet. 2016 Dec 15;25(24):5460-5471. doi: 10.1093/hmg/ddw362.

PMID:
27798111
20.

Host-Guest Complexes of Carboxylated Pillar[n]arenes With Drugs.

Wheate NJ, Dickson KA, Kim RR, Nematollahi A, Macquart RB, Kayser V, Yu G, Church WB, Marsh DJ.

J Pharm Sci. 2016 Dec;105(12):3615-3625. doi: 10.1016/j.xphs.2016.09.008. Epub 2016 Oct 21.

PMID:
27776769
21.

Modeling of Kidney Hemodynamics: Probability-Based Topology of an Arterial Network.

Postnov DD, Marsh DJ, Postnov DE, Braunstein TH, Holstein-Rathlou NH, Martens EA, Sosnovtseva O.

PLoS Comput Biol. 2016 Jul 22;12(7):e1004922. doi: 10.1371/journal.pcbi.1004922. eCollection 2016 Jul.

22.

Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.

Cole AJ, Dwight T, Gill AJ, Dickson KA, Zhu Y, Clarkson A, Gard GB, Maidens J, Valmadre S, Clifton-Bligh R, Marsh DJ.

Sci Rep. 2016 May 18;6:26191. doi: 10.1038/srep26191.

23.

Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs.

Shah JS, Soon PS, Marsh DJ.

PLoS One. 2016 Apr 7;11(4):e0153200. doi: 10.1371/journal.pone.0153200. eCollection 2016.

24.

Modified 'Mustardé' suture technique: Novel way of inserting mattress sutures to create the antihelical fold.

Murugesan L, Welman K, Marsh DJ.

J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):284-5. doi: 10.1016/j.bjps.2015.10.009. Epub 2015 Oct 22. No abstract available.

PMID:
26526861
25.

A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer.

Chung L, Phillips L, Lin MZ, Moore K, Marsh DJ, Boyle FM, Baxter RC.

Cancer Lett. 2015 Nov 1;368(1):64-70. doi: 10.1016/j.canlet.2015.07.046. Epub 2015 Aug 11.

PMID:
26276712
26.

Assessing the augmented breast: a blinded study comparing round and anatomical form-stable implants.

Al-Ajam Y, Marsh DJ, Mohan AT, Hamilton S.

Aesthet Surg J. 2015 Mar;35(3):273-8. doi: 10.1093/asj/sju053.

PMID:
25805281
27.

Networks regulating ubiquitin and ubiquitin-like proteins promise new therapeutic targets.

Marsh DJ.

Endocr Relat Cancer. 2015 Feb;22(1):E1-3. doi: 10.1530/ERC-14-0585. Epub 2014 Dec 30. No abstract available.

PMID:
25549994
28.

Factors that may influence the willingness of cancer patients to consent for biobanking.

Pillai U, Phillips K, Wilkins G, Baxter RC, Benn DE, Parker NR, Smith RC, Marsh DJ.

Biopreserv Biobank. 2014 Dec;12(6):409-14. doi: 10.1089/bio.2014.0039.

PMID:
25496153
29.

Abdominoplasty and seroma: a prospective randomised study comparing scalpel and handheld electrocautery dissection.

Marsh DJ, Fox A, Grobbelaar AO, Chana JS.

J Plast Reconstr Aesthet Surg. 2015 Feb;68(2):192-6. doi: 10.1016/j.bjps.2014.10.004. Epub 2014 Oct 13.

PMID:
25456290
30.

Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.

Kan CW, Howell VM, Hahn MA, Marsh DJ.

Genes Chromosomes Cancer. 2015 Jan;54(1):1-19. doi: 10.1002/gcc.22221. Epub 2014 Oct 3. Review.

PMID:
25280227
31.

Synchronized renal blood flow dynamics mapped with wavelet analysis of laser speckle flowmetry data.

Brazhe AR, Marsh DJ, Holstein-Rathlou NH, Sosnovtseva O.

PLoS One. 2014 Sep 12;9(9):e105879. doi: 10.1371/journal.pone.0105879. eCollection 2014.

32.

Tensor interpretation of BICEP2 results severely constrains axion dark matter.

Marsh DJ, Grin D, Hlozek R, Ferreira PG.

Phys Rev Lett. 2014 Jul 4;113(1):011801. Epub 2014 Jul 2.

PMID:
25032918
33.

Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.

Marsh DJ, Shah JS, Cole AJ.

Front Oncol. 2014 Jun 12;4:144. doi: 10.3389/fonc.2014.00144. eCollection 2014. Review.

34.

Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.

Chung L, Moore K, Phillips L, Boyle FM, Marsh DJ, Baxter RC.

Breast Cancer Res. 2014 Jun 16;16(3):R63. doi: 10.1186/bcr3676.

35.

Confirming perforator patency and cross midline arterial arborisation in DIEP flap surgery.

Marsh DJ, Patel N, Ramakrishnan VV.

J Plast Reconstr Aesthet Surg. 2014 Sep;67(9):1300-1. doi: 10.1016/j.bjps.2014.05.006. Epub 2014 May 27. No abstract available.

PMID:
24917375
36.

Histone H2B monoubiquitination: roles to play in human malignancy.

Cole AJ, Clifton-Bligh R, Marsh DJ.

Endocr Relat Cancer. 2015 Feb;22(1):T19-33. doi: 10.1530/ERC-14-0185. Epub 2014 Jun 2. Review.

PMID:
24891457
37.

Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.

Neuner P, Peier AM, Talamo F, Ingallinella P, Lahm A, Barbato G, Di Marco A, Desai K, Zytko K, Qian Y, Du X, Ricci D, Monteagudo E, Laufer R, Pocai A, Bianchi E, Marsh DJ, Pessi A.

J Pept Sci. 2014 Jan;20(1):7-19. doi: 10.1002/psc.2582. Epub 2013 Nov 13.

PMID:
24222478
38.

A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity.

Bianchi E, Carrington PE, Ingallinella P, Finotto M, Santoprete A, Petrov A, Eiermann G, Kosinski J, Marsh DJ, Pocai A, SinhaRoy R, Pessi A.

Bioorg Med Chem. 2013 Nov 15;21(22):7064-73. doi: 10.1016/j.bmc.2013.09.016. Epub 2013 Sep 19.

PMID:
24094437
39.

Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action.

Liu J, Gorski JN, Gold SJ, Chen D, Chen S, Forrest G, Itoh Y, Marsh DJ, McLaren DG, Shen Z, Sonatore L, Carballo-Jane E, Craw S, Guan X, Karanam B, Sakaki J, Szeto D, Tong X, Xiao J, Yoshimoto R, Yu H, Roddy TP, Balkovec J, Pinto S.

Obesity (Silver Spring). 2013 Jul;21(7):1406-15. doi: 10.1002/oby.20193. Epub 2013 May 13.

40.

Tissue biomarkers of breast cancer and their association with conventional pathologic features.

Chung L, Shibli S, Moore K, Elder EE, Boyle FM, Marsh DJ, Baxter RC.

Br J Cancer. 2013 Feb 5;108(2):351-60. doi: 10.1038/bjc.2012.552. Epub 2013 Jan 8.

41.

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.

Kan CW, Hahn MA, Gard GB, Maidens J, Huh JY, Marsh DJ, Howell VM.

BMC Cancer. 2012 Dec 28;12:627. doi: 10.1186/1471-2407-12-627.

42.

Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents.

Day JW, Gelfanov V, Smiley D, Carrington PE, Eiermann G, Chicchi G, Erion MD, Gidda J, Thornberry NA, Tschöp MH, Marsh DJ, SinhaRoy R, DiMarchi R, Pocai A.

Biopolymers. 2012;98(5):443-50. doi: 10.1002/bip.22072.

PMID:
23203689
43.

Dynamics of nephron-vascular network.

Postnov DD, Postnov DE, Marsh DJ, Holstein-Rathlou NH, Sosnovtseva OV.

Bull Math Biol. 2012 Dec;74(12):2820-41. doi: 10.1007/s11538-012-9781-6. Epub 2012 Oct 19.

PMID:
23081729
44.

Multinephron dynamics on the renal vascular network.

Marsh DJ, Wexler AS, Brazhe A, Postnov DE, Sosnovtseva OV, Holstein-Rathlou NH.

Am J Physiol Renal Physiol. 2013 Jan 1;304(1):F88-F102. doi: 10.1152/ajprenal.00237.2012. Epub 2012 Sep 12.

45.

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

Ingallinella P, Peier AM, Pocai A, Marco AD, Desai K, Zytko K, Qian Y, Du X, Cellucci A, Monteagudo E, Laufer R, Bianchi E, Marsh DJ, Pessi A.

Bioorg Med Chem. 2012 Aug 1;20(15):4751-9. doi: 10.1016/j.bmc.2012.06.003. Epub 2012 Jun 9.

PMID:
22771182
46.

Gonadotropin signalling in epithelial ovarian cancer.

Mertens-Walker I, Baxter RC, Marsh DJ.

Cancer Lett. 2012 Nov 28;324(2):152-9. doi: 10.1016/j.canlet.2012.05.017. Epub 2012 May 22. Review.

PMID:
22634496
47.

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ.

PLoS One. 2012;7(4):e35240. doi: 10.1371/journal.pone.0035240. Epub 2012 Apr 10.

48.

The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.

Chobanian HR, Guo Y, Liu P, Lanza TJ Jr, Chioda M, Chang L, Kelly TM, Kan Y, Palyha O, Guan XM, Marsh DJ, Metzger JM, Raustad K, Wang SP, Strack AM, Gorski JN, Miller R, Pang J, Lyons K, Dragovic J, Ning JG, Schafer WA, Welch CJ, Gong X, Gao YD, Hornak V, Reitman ML, Nargund RP, Lin LS.

Bioorg Med Chem. 2012 May 1;20(9):2845-9. doi: 10.1016/j.bmc.2012.03.029. Epub 2012 Mar 24.

PMID:
22494842
49.

The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.

Kosinski JR, Hubert J, Carrington PE, Chicchi GG, Mu J, Miller C, Cao J, Bianchi E, Pessi A, Sinharoy R, Marsh DJ, Pocai A.

Obesity (Silver Spring). 2012 Aug;20(8):1566-71. doi: 10.1038/oby.2012.67. Epub 2012 Mar 16.

50.

Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.

Chobanian HR, Guo Y, Liu P, Chioda M, Lanza TJ Jr, Chang L, Kelly TM, Kan Y, Palyha O, Guan XM, Marsh DJ, Metzger JM, Gorski JN, Raustad K, Wang SP, Strack AM, Miller R, Pang J, Madeira M, Lyons K, Dragovic J, Reitman ML, Nargund RP, Lin LS.

ACS Med Chem Lett. 2012 Jan 21;3(3):252-6. doi: 10.1021/ml200304j. eCollection 2012 Mar 8.

Supplemental Content

Loading ...
Support Center